(AEHR) Aehr Test Systems - Ratings and Ratios
Test Systems, Semiconductor Devices, Wafer Contactors, Burn-in Systems, Test
AEHR EPS (Earnings per Share)
AEHR Revenue
Description: AEHR Aehr Test Systems
Aehr Test Systems is a leading provider of test solutions for the semiconductor industry, offering a range of products that enable testing, burning-in, and stabilization of various semiconductor devices, including power semiconductors, sensors, memory semiconductors, and photonics devices.
The companys product portfolio, including FOX-XP, FOX-NP, FOX-CP, and FOX WaferPak Contactor, is designed to cater to the growing demand for advanced semiconductor testing solutions. With a strong focus on innovation, Aehr Test Systems is well-positioned to capitalize on the increasing complexity of semiconductor devices and the need for more efficient testing solutions.
From a financial perspective, Aehr Test Systems has a market capitalization of $464.43M USD, indicating a moderate size. The companys Return on Equity (RoE) of 18.99% suggests a relatively strong profitability. To further evaluate the companys performance, we can examine additional KPIs such as Revenue Growth Rate, Gross Margin, and Operating Cash Flow Margin.
Some key performance indicators (KPIs) to monitor for Aehr Test Systems include: Revenue Growth Rate (e.g., 10%+ YoY growth indicating a strong demand for their test solutions), Gross Margin (e.g., 40%+ indicating a healthy profitability), and Operating Cash Flow Margin (e.g., 15%+ indicating a robust cash generation capability). Additionally, the companys ability to maintain a strong order backlog and its research and development (R&D) expenses as a percentage of revenue (e.g., 10%+ indicating a commitment to innovation) are also important metrics to track.
To gain a deeper understanding of Aehr Test Systems competitive position and growth prospects, it is essential to analyze the companys market share, customer base, and product roadmap. This can involve examining the companys relationships with key customers, its partnerships with other industry players, and its investments in emerging technologies such as artificial intelligence (AI) and the Internet of Things (IoT).
AEHR Stock Overview
| Market Cap in USD | 734m |
| Sub-Industry | Semiconductor Materials & Equipment |
| IPO / Inception | 1997-08-14 |
AEHR Stock Ratings
| Growth Rating | 42.7% |
| Fundamental | 36.6% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 91.7% |
| Analyst Rating | 4.0 of 5 |
AEHR Dividends
Currently no dividends paidAEHR Growth Ratios
| Growth Correlation 3m | 90.4% |
| Growth Correlation 12m | 17.3% |
| Growth Correlation 5y | 40.9% |
| CAGR 5y | 22.87% |
| CAGR/Max DD 3y | 0.26 |
| CAGR/Mean DD 3y | 0.34 |
| Sharpe Ratio 12m | -1.05 |
| Alpha | 0.08 |
| Beta | 0.547 |
| Volatility | 92.27% |
| Current Volume | 1215.7k |
| Average Volume 20d | 1486.4k |
| Stop Loss | 26.3 (-7.2%) |
| Signal | 0.53 |
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-3.91m TTM) > 0 and > 6% of Revenue (6% = 3.54m TTM) |
| FCFTA -0.08 (>2.0%) and ΔFCFTA -9.13pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 124.0% (prev 131.9%; Δ -7.86pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.05 (>3.0%) and CFO -7.40m <= Net Income -3.91m (YES >=105%, WARN >=100%) |
| Net Debt (-13.7m) to EBITDA (515.0k) ratio: -26.60 <= 3.0 (WARN <= 3.5) |
| Current Ratio 5.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (29.8m) change vs 12m ago 1.24% (target <= -2.0% for YES) |
| Gross Margin 40.59% (prev 49.15%; Δ -8.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 42.67% (prev 51.77%; Δ -9.10pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' 1.74
| (A) 0.49 = (Total Current Assets 88.8m - Total Current Liabilities 15.6m) / Total Assets 148.5m |
| (B) -0.16 = Retained Earnings (Balance) -23.1m / Total Assets 148.5m |
| (C) -0.01 = EBIT TTM -960.0k / Avg Total Assets 138.2m |
| (D) -0.89 = Book Value of Equity -22.9m / Total Liabilities 25.6m |
| Total Rating: 1.74 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 36.58
| 1. Piotroski 1.0pt = -4.0 |
| 2. FCF Yield -1.75% = -0.87 |
| 3. FCF Margin -21.01% = -7.50 |
| 4. Debt/Equity 0.01 = 2.50 |
| 5. Debt/Ebitda 1.77 = 0.46 |
| 6. ROIC - WACC (= -0.78)% = -0.97 |
| 7. RoE -3.17% = -0.53 |
| 8. Rev. Trend -26.44% = -1.98 |
| 9. EPS Trend -10.39% = -0.52 |
What is the price of AEHR shares?
Over the past week, the price has changed by +7.31%, over one month by +46.11%, over three months by +149.60% and over the past year by +127.19%.
Is Aehr Test Systems a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AEHR is around 27.86 USD . This means that AEHR is currently overvalued and has a potential downside of -1.66%.
Is AEHR a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AEHR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.5 | -41.8% |
| Analysts Target Price | 16.5 | -41.8% |
| ValueRay Target Price | 30.9 | 9.2% |
Last update: 2025-09-05 04:30
AEHR Fundamental Data Overview
CCE Cash And Equivalents = 24.5m USD (last quarter)
P/S = 12.4393
P/B = 6.0575
P/EG = 5.92
Beta = 2.357
Revenue TTM = 59.0m USD
EBIT TTM = -960.0k USD
EBITDA TTM = 515.0k USD
Long Term Debt = unknown (0.0)
Short Term Debt = 909.0k USD (from shortTermDebt, last quarter)
Debt = 909.0k USD (Calculated: Short Term 909.0k + Long Term 0.0)
Net Debt = -13.7m USD (from netDebt column, last quarter)
Enterprise Value = 709.9m USD (733.5m + Debt 909.0k - CCE 24.5m)
Interest Coverage Ratio = unknown (Ebit TTM -960.0k / Interest Expense TTM 0.0)
FCF Yield = -1.75% (FCF TTM -12.4m / Enterprise Value 709.9m)
FCF Margin = -21.01% (FCF TTM -12.4m / Revenue TTM 59.0m)
Net Margin = -6.63% (Net Income TTM -3.91m / Revenue TTM 59.0m)
Gross Margin = 40.59% ((Revenue TTM 59.0m - Cost of Revenue TTM 35.0m) / Revenue TTM)
Tobins Q-Ratio = -31.02 (set to none) (Enterprise Value 709.9m / Book Value Of Equity -22.9m)
Interest Expense / Debt = 53.14% (Interest Expense 483.0k / Debt 909.0k)
Taxrate = 21.0% (US default)
NOPAT = -960.0k (EBIT -960.0k, no tax applied on loss)
Current Ratio = 5.68 (Total Current Assets 88.8m / Total Current Liabilities 15.6m)
Debt / Equity = 0.01 (Debt 909.0k / last Quarter total Stockholder Equity 122.9m)
Debt / EBITDA = 1.77 (Net Debt -13.7m / EBITDA 515.0k)
Debt / FCF = -0.07 (Debt 909.0k / FCF TTM -12.4m)
Total Stockholder Equity = 123.2m (last 4 quarters mean)
RoA = -2.63% (Net Income -3.91m, Total Assets 148.5m )
RoE = -3.17% (Net Income TTM -3.91m / Total Stockholder Equity 123.2m)
RoCE = -0.78% (Ebit -960.0k / (Equity 123.2m + L.T.Debt 0.0))
RoIC = -0.78% (NOPAT -960.0k / Invested Capital 123.2m)
WACC = unknown (E(733.5m)/V(734.4m) * Re(8.03%)) + (D(909.0k)/V(734.4m) * Rd(none%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 65.65 | Cagr: 0.32%
Discount Rate = 8.03% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -12.4m)
EPS Correlation: -10.39 | EPS CAGR: -32.14% | SUE: 0.0 | # QB: 0
Revenue Correlation: -26.44 | Revenue CAGR: -1.99% | SUE: 0.0 | # QB: 0
Additional Sources for AEHR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle